About Steven Chartier
Steven Chartier is a president and co-chief executive officer, director at Bioventrix.
Steven Chartier first appears on SEC filings in 2022.
Experience
This experience comes from Steven Chartier's profile and from SEC filings. For roles taken from filings, the years are when the filings name Steven Chartier in the role, so the role may have started earlier or lasted longer.
Bioventrix, Inc. Current
President and Co-CEO (2021 – Present)
Director
2021 – Present · Mansfield, MA
Develops an investigational heart device for surgeons treating patients with heart failure.
CL
CAVIC Consulting, llc Current
Managing Director, Owner
2015 – Present
CM
Conformal Medical
Vice President Regulatory and Quality
2024 – 2025
SL
Sirtex Medical Limited
Vice President of Clinical Affairs
2020 – 2021
CF
Cardiovascular Clinical Sciences Foundation
President and CEO
2019 – 2020
AT
Anika Therapeutics
Vice President of Regulatory and Clinical Affairs
2017 – 2019
II
Infraredx, Inc.
Chief Operations Officer
2007 – 2015
NB
Nucryst Pharmaceuticals (Formerly Westaim Biomedical)
Sr. Director Program Management
1998 – 2007
BI
Biogen
Clinical Project Manager
1996 – 1998
BC
Beth Israel Deaconess Medical Center
Clinical Trials Coordinator
1995 – 1996
DI
Dana-Farber Cancer Institute
Bone Marrow Transplantation Lab Manager
1990 – 1995
Key Colleagues at Startups
The people Steven Chartier works with at each company, as listed on that company's latest Form D.
Bioventrix, Inc. · Form D, Oct 8, 2026
Dave Richmond
Executive officer and director
Rishi Puri
Director
MR
Mark Ravich
Independent Board Member
William Abraham
Director